Lv4
435 积分 2021-02-19 加入
Metformin for Knee Osteoarthritis in Patients With Overweight or Obesity
7天前
已关闭
An update on current type 2 diabetes mellitus (T2DM) druggable targets and drugs targeting them
9天前
已完结
SGLT-2 Inhibitors and Nephroprotection in Patients with Diabetic and Non-diabetic Chronic Kidney Disease
10天前
已完结
Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
10天前
已完结
Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
10天前
已完结
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
10天前
已完结
Metformin for knee osteoarthritis with overweight or obesity: a community-based randomised, double-blind, placebo-controlled trial
23天前
已关闭
Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial
1个月前
已完结
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
1个月前
已完结
皖公网安备34019202002308
